SHR-2042

• Target:

  Glucagon Receptor

• Related Pathways:

  GPCR/G Protein

• Bioactivity:

  SHR-2042 is a selective agonist of the GLP-1 receptor. By activating the GLP-1 receptor, it enhances insulin secretion and suppresses glucagon secretion, thereby improving blood sugar regulation. When combined with sodium N- (8-[2-hydroxybenzoyl] amino) caprylate (SNAC), it forms micelles that promote monomerization, increasing oral absorption efficiency.

• Molecular Formula:

  C205H314N48O63

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C